Clinical Trials in Dongyang, China
8 recruiting
Showing 1–16 of 16 trials
Recruiting
Phase 3
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma
Marginal Zone LymphomaRelapsed/Refractory Follicular Lymphoma
BeiGene780 enrolled277 locationsNCT05100862
Recruiting
Phase 2
Carboplatin/Cisplatin + Etoposide + Benmelstobart Sequential Benmelstobart Combined With Anlotinib Versus Carboplatin/Cisplatin + Etoposide + Tislelizumab Sequential Tislelizumab in the Treatment of Extensive Stage Small Cell Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.134 enrolled32 locationsNCT06897579
Recruiting
Real World Evidence in China: Faricimab Use in Diabetic Macular Edema, Retinal Vein Occlusion, and Neovascular Age-Related Macular Degeneration (The Farseeing Study)
Neovascular Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
Hoffmann-La Roche1,000 enrolled41 locationsNCT06439576
Recruiting
Not Applicable
The Efficacy of Remimazolam on Incidence of Hypoxia During Sedated Transvaginal Oocyte Retrieval: A Multicenter Randomized Controlled Trial.
InfertilityHypoxiaInfertility Assisted Reproductive Technology
Diansan Su400 enrolled3 locationsNCT07335536
Recruiting
Phase 3
Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma
Non-Hodgkin's LymphomaHematopoietic Stem Cell Mobilization
The Affiliated People's Hospital of Ningbo University99 enrolled17 locationsNCT06520163
Recruiting
Phase 2
A Study of T-DXd as Monotherapy or in Combination With Anti-cancer Agents in Patients With Selected HER2-expressing Tumors
Advanced Solid Tumors (Excluding Gastric Cancer and Breast Cancer)
AstraZeneca175 enrolled31 locationsNCT06271837
Recruiting
Phase 2
Edaravone Dexborneol Sublingual Tablet for the PSCI in Acute Ischemic Stroke Patients
Post-stroke Cognitive Impairment
Simcere Pharmaceutical Co., Ltd226 enrolled21 locationsNCT06315231
Recruiting
Phase 2
Orelabrutinib Combined With Rituximab as First-line Systemic Treatment for Marginal Zone Lymphoma
Marginal Zone Lymphoma (MZL)
Second Affiliated Hospital, School of Medicine, Zhejiang University51 enrolled18 locationsNCT07022223
Recruiting
Not Applicable
Non-inferiority Study of the Effect of Non-cooling Blanket on Body Temperature in Patients With Heat Stroke
Heat Stroke
Second Affiliated Hospital, School of Medicine, Zhejiang University100 enrolled7 locationsNCT05923931
Recruiting
Not Applicable
Application of an Early In-Hospital Temperature Management Protocol for Heat Stroke Patients
Heat Stroke
Second Affiliated Hospital, School of Medicine, Zhejiang University188 enrolled7 locationsNCT06537557
Recruiting
Early Body Temperature Targets and Relationship With Prognosis in Patients With Heat Stroke
Heat Stroke
Second Affiliated Hospital, School of Medicine, Zhejiang University100 enrolled6 locationsNCT05921682
Recruiting
Not Applicable
The Relationship Between Normal Saline Infusion and Acute Kidney Injury in Heat Stroke
Heat Stroke
Second Affiliated Hospital, School of Medicine, Zhejiang University190 enrolled7 locationsNCT05921695
Recruiting
Phase 3
Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients
Multiple MyelomaHematopoietic Stem Cell Mobilization
The Affiliated People's Hospital of Ningbo University99 enrolled16 locationsNCT06520176
Recruiting
Not Applicable
Base Curves of Bandage Contact Lenses and Their Effects on Post Trans-PRK Vision and Pain
Myopia
Dongyang People's Hospital36 enrolled1 locationNCT06393855
Recruiting
Not Applicable
Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies
Multiple MyelomaLymphoma
The Affiliated People's Hospital of Ningbo University68 enrolled14 locationsNCT05536154
Recruiting
Phase 2
Furmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC With Uncleared ctDNA
Non-small Cell Lung Cancer
Sun Yat-sen University280 enrolled26 locationsNCT05334277